Profile data is unavailable for this security.
About the company
SanBio Co Ltd is engaged in the regenerative cell business using allogeneic stem cells. The Company has the research and development base in the United States and conducts research, development, manufacture and sale of regenerative cell medicines in Japan. The Company aims to sell therapeutic agents for diseases with high unmet medical needs, mainly in diseases of the central nervous system. It is involved in the manufacture, development, non-clinical studies, clinical trials of technologies introduced from research institutes such as universities. The Company has five regenerative cell drugs, including the main product candidate SB623 (nerve regenerative cells), SB618 (function-enhancing type & Mesenchymal stem cells), SB308 (muscle stem cells), MSC1 (mesenchymal stem cells), and MSC2 (mesenchymal stem cells).
- Revenue in JPY (TTM)0.00
- Net income in JPY-2.64bn
- Incorporated2013
- Employees29.00
- LocationSanBio Co Ltd13F, St. Luke Tower, 8-1, Akashi-choCHUO-KU 104-0044JapanJPN
- Phone+81 362643481
- Websitehttps://www.sanbio.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TAIKO PHARMACEUTICAL CO LTD | 6.33bn | -2.90bn | 18.63bn | 208.00 | -- | 2.49 | -- | 2.94 | -58.49 | -58.49 | 129.20 | 148.04 | 0.462 | 2.04 | 3.44 | 30,432,690.00 | -21.14 | -- | -26.00 | -- | 44.27 | -- | -45.75 | -- | 2.92 | -- | 0.2811 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
Astena Holdings Co Ltd | 52.63bn | 1.62bn | 19.79bn | 1.40k | 11.79 | 0.6686 | 5.15 | 0.3761 | 40.98 | 40.98 | 1,332.61 | 722.46 | 0.8127 | 3.31 | 2.76 | 37,482,540.00 | 2.49 | 2.49 | 4.44 | 4.44 | 32.27 | 25.33 | 3.06 | 2.32 | 0.8713 | -- | 0.3517 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
Medical Data Vision Co Ltd | 6.25bn | 688.02m | 21.25bn | 262.00 | 29.48 | 5.09 | 28.11 | 3.40 | 18.01 | 18.01 | 163.57 | 104.34 | 1.15 | 282.07 | 7.84 | 23,847,790.00 | 12.18 | 16.16 | 17.01 | 20.88 | 77.43 | 81.90 | 10.55 | 15.52 | 2.72 | 13.48 | 0.00 | 19.98 | 5.15 | 12.40 | 12.48 | 69.75 | -23.95 | -- |
Fuso Pharmaceutical Industries Ltd | 55.41bn | 1.38bn | 21.73bn | 1.31k | 14.39 | 0.5358 | 7.58 | 0.3922 | 159.77 | 159.77 | 6,435.26 | 4,290.49 | 0.7474 | 3.12 | 2.43 | -- | 1.86 | 1.91 | 3.06 | 3.09 | 24.98 | 26.92 | 2.49 | 2.69 | 1.04 | 54.56 | 0.2576 | 41.17 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
Pharma Foods International Co., Ltd. | 65.08bn | 4.76bn | 25.47bn | 670.00 | 5.30 | 2.67 | 4.74 | 0.3914 | 165.17 | 165.17 | 2,257.80 | 327.80 | 1.84 | 2.22 | 12.71 | 97,135,820.00 | 13.44 | 8.40 | 48.12 | 19.20 | 79.89 | 81.34 | 7.32 | 3.85 | 0.8449 | 91.33 | 0.6839 | 28.26 | 13.94 | 53.90 | 923.80 | 57.92 | 51.63 | -- |
Koa Shoji Holdings Co Ltd | 22.67bn | 2.87bn | 28.41bn | 297.00 | 9.90 | 1.25 | 7.93 | 1.25 | 72.45 | 72.45 | 572.11 | 573.53 | 0.7878 | 5.56 | 2.62 | 76,317,420.00 | 9.98 | 7.91 | 12.08 | 9.93 | 29.95 | 28.74 | 12.66 | 10.48 | 3.86 | 36.55 | 0.1142 | 19.64 | 8.35 | 8.27 | 13.90 | 29.60 | -21.26 | 15.52 |
StemRIM Inc | 2.35bn | 179.40m | 28.48bn | 44.00 | 135.25 | 2.90 | -- | 12.12 | -0.1097 | -0.1097 | 37.43 | 159.71 | 0.2453 | -- | -- | 53,409,090.00 | 1.87 | -6.71 | 1.89 | -6.83 | -- | -- | 7.63 | -45.80 | 78.90 | 652.72 | 0.00 | -- | 10,128.06 | 63.68 | 108.64 | -- | -- | -- |
Mizuho Medy Co Ltd | 11.34bn | 4.00bn | 32.77bn | 180.00 | 8.20 | 2.14 | 7.82 | 2.89 | 419.74 | 419.74 | 1,190.62 | 1,607.77 | 0.6484 | 1.87 | 2.99 | 62,999,830.00 | 22.86 | 31.46 | 26.23 | 39.78 | 73.41 | 74.85 | 35.25 | 33.64 | 6.41 | -- | 0.00 | 34.83 | -37.49 | 11.34 | -51.85 | 32.64 | -17.74 | 32.85 |
SanBio Co Ltd | 0.00 | -2.64bn | 34.73bn | 29.00 | -- | 12.31 | -- | -- | -40.50 | -40.50 | 0.00 | 41.11 | 0.00 | -- | -- | 0.00 | -43.74 | -42.00 | -52.38 | -48.88 | -- | -- | -- | -4,790.72 | -- | -- | 0.1923 | -- | -- | -- | 52.44 | -- | 53.94 | -- |
Daito Pharmaceutical Co Ltd | 45.19bn | 3.28bn | 34.94bn | 1.01k | 10.71 | 0.6721 | 5.14 | 0.7732 | 207.85 | 207.85 | 2,864.81 | 3,311.81 | 0.6193 | 1.81 | 2.65 | 44,701,280.00 | 4.35 | 6.99 | 5.64 | 9.29 | 21.38 | 22.71 | 7.03 | 8.83 | 1.15 | -- | 0.1231 | 17.08 | 3.77 | 2.49 | -22.88 | 3.43 | 7.48 | 12.70 |
Fuji Pharma Co Ltd | 43.05bn | 5.92bn | 36.76bn | 1.62k | 6.10 | 0.8194 | 3.99 | 0.8538 | 243.57 | 243.57 | 1,771.38 | 1,812.38 | 0.5071 | 1.34 | 3.21 | 26,558,910.00 | 6.97 | 4.10 | 10.56 | 5.58 | 39.78 | 42.41 | 13.75 | 7.55 | 0.5895 | -- | 0.3826 | 31.17 | 15.42 | 1.52 | 27.41 | 0.3709 | 19.04 | 5.73 |
Cuorips Inc | 23.10m | -632.18m | 40.08bn | 46.00 | -- | 6.69 | -- | 1,734.90 | -86.04 | -86.04 | 3.14 | 752.26 | 0.0047 | 4.66 | 17.57 | -- | -12.94 | -- | -13.30 | -- | 41.69 | -- | -2,736.49 | -- | 33.80 | -- | -- | -- | -39.65 | -- | -39.84 | -- | -- | -- |
Seikagaku Corp | 36.21bn | 2.19bn | 44.71bn | 976.00 | 19.64 | 0.594 | 11.48 | 1.23 | 40.08 | 40.08 | 663.80 | 1,324.81 | 0.4601 | 2.06 | 5.02 | -- | 2.78 | 0.4261 | 3.05 | 0.4678 | 46.60 | 54.18 | 6.04 | 0.9814 | 4.47 | -- | 0.0055 | 415.52 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
Holder | Shares | % Held |
---|---|---|
Norges Bank Investment Managementas of 31 Dec 2023 | 1.19m | 1.73% |
BlackRock Fund Advisorsas of 09 May 2024 | 537.90k | 0.78% |
Simplex Asset Management Co., Ltd.as of 09 May 2024 | 250.80k | 0.37% |
SSgA Funds Management, Inc.as of 09 May 2024 | 211.30k | 0.31% |
BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 61.30k | 0.09% |
Nomura Asset Management Co., Ltd.as of 30 Nov 2022 | 59.00k | 0.09% |
TIAA-CREF Investment Management LLCas of 31 Mar 2024 | 36.82k | 0.05% |
The Vanguard Group, Inc.as of 30 Apr 2024 | 20.70k | 0.03% |
Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 20.09k | 0.03% |
KLP Kapitalforvaltning ASas of 30 Apr 2024 | 19.60k | 0.03% |